top of page
Our team, in conjunction with the Maternal-Fetal Medicine unit of the Hospital Austral in Buenos Aires, is developing a protocol to use Previfenon® during the third trimester of pregnancy to obtain improvements in the development of the nervous system and in the intellectual and behavioral capacity of these children.
Protection of Health Workers Against COVID-19 (HERD)
The purpose of this clinical trial is to determine the efficacy of Previfenon® (EGCG) to prevent COVID-19, enhance systemic immunity, and decrease the frequency and intensity of selected symptoms when used as pre-exposure chemoprophylaxis to SARS-CoV-2.
bottom of page